BioAtla (BCAB) Balance Sheet: Assets & Liabilities

BioAtla (BCAB) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), BioAtla reported total assets of $13.83M and total liabilities of $50.02M. Shareholders' equity was negative at −$36.19M, meaning liabilities exceed assets. Total debt stood at $6.20M against $7.12M in cash and short-term investments, a net cash position of $918.00K.

BioAtla Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for BioAtla, Inc. (BCAB) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	7.12	49.05	111.47	215.51	244.98	238.61	3.70	10.86
Cash & Short-Term Investments	7.12	49.05	111.47	215.51	244.98	238.61	3.70	10.86
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.90	0.45	4.94	4.92	2.31	2.08	0.80	1.80
Total Current Assets	8.01	51.23	116.41	220.43	247.29	240.68	4.51	12.66
Non-Current Assets
Property, Plant & Equipment (Net)	5.65	1.19	3.10	5.15	6.98	4.10	4.68	3.88
Other Non-Current Assets	0.16	0.00	0.15	0.15	0.15	0.15	0.15	0.10
Total Non-Current Assets	5.82	1.19	3.25	5.31	7.13	4.26	4.83	3.98
Total Assets	13.83	52.42	119.66	225.74	254.42	244.94	9.34	16.64
Current Liabilities
Accounts Payable	8.19	1.90	26.72	21.61	1.18	2.46	5.14	1.96
Short-Term Debt	1.43	0.84	1.62	1.52	1.39	0.00	9.71	0.00
Accrued Liabilities	8.12	9.08	22.90	17.38	14.57	8.47	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	19.81	1.42	0.17
Other Current Liabilities	12.30	11.80	22.90	17.38	17.25	10.00	10.45	7.07
Total Current Liabilities	21.92	14.54	28.34	23.13	19.81	32.26	26.72	9.20
Non-Current Liabilities
Long-Term Debt	4.77	0.00	0.84	2.46	3.98	0.68	8.41	10.41
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	2.81	4.59
Other Non-Current Liabilities	23.32	19.81	19.81	19.81	19.81	2.02	8.59	15.99
Total Non-Current Liabilities	28.10	23.62	20.64	22.27	23.79	2.70	38.63	35.89
Total Liabilities	50.02	38.16	48.99	45.40	43.60	34.96	65.35	45.08
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.00	0.00	0.75	0.75
Retained Earnings	-545.65	-486.04	-416.26	-292.80	-186.32	-90.92	-148.35	-118.56
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	-	0.00	0.00	-1.38
Additional Paid-in Capital	509.45	500.30	486.93	473.14	397.14	300.89	2.30	0.00
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00	-0.05	0.02
Shares Outstanding	1.27	1.16	0.96	2.14	37.29	-	-	-
Total Stockholders' Equity	-36.19	14.27	70.67	180.34	210.82	209.97	-55.96	-28.47
Total Liabilities & Equity	13.83	52.42	119.66	225.74	254.42	244.94	9.34	16.64

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About BioAtla Balance Sheet

How much debt does BioAtla have?

BioAtla had total debt of $6.20M as of Dec 31, 2025, against $7.12M in cash and short-term investments. Total debt was $836.00K a year earlier.

What are BioAtla's total assets?

BioAtla reported total assets of $13.83M as of Dec 31, 2025, down 73.6% from $52.42M a year earlier. Total liabilities were $50.02M.

What is BioAtla's shareholders' equity?

BioAtla's shareholders' equity was negative at −$36.19M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition